 - Concurrent medicalarthritic disease that could confound or interfere with evaluation of pain or efficacy including: Inflammatory arthritis e.g., rheumatoid arthritis, systemic lupus, spondyloarthropathy, psoriatic arthritis, polymyalgia rheumatica, gout, episodes of acute monarticular arthritis clinically consistent with pseudogout, Pagets disease affecting the study joint, a history of septic arthritis or avascular necrosis or intra-articular fracture of the study joint, Wilsons disease, hemochromatosis, alkaptonuria, or primary osteochondromatosis. 